The 5th Circuit Court of Appeals should reverse the Federal Trade Commission’s decision in Illumina Inc. v. FTC, “a paradigmatic example” of how the agency’s practices violate the Constitution’s due process clause, AHA said in a friend-of-the-court brief filed in the case. 

“With one-sided procedures that favor the agency and a win-loss tally that proves it, the only possible conclusion is that the FTC is not a fair, neutral, and unbiased tribunal, as required by the Due Process Clause,” the brief notes. “In both appearance and reality, this case does not display fairness and neutrality consistent with the Constitution. Unique among federal agencies, it is sadly par for the course with the FTC. … Whether it is an acquisition that prevents a rural hospital from closing or, as here, the future of cutting-edge, life-saving medical technology, the FTC’s unfair practices have stood in the way of improved healthcare again and again. It is long past time to put an end to the FTC’s unconstitutional enforcement practices.”

Headline
The Centers for Medicare & Medicaid Services and the Food and Drug Administration April 23 announced a new pathway to expedite access to certain FDA-…
Headline
The AHA March 24 commented to the Centers for Medicare & Medicaid Services on upcoming requirements from the Consolidated Appropriations Act of 2026…
Headline
The AHA Feb. 27 shared recommendations on the Health Data, Technology and Interoperability: ASTP/ONC Deregulatory Actions to Unleash Prosperity proposed rule,…
Headline
The AHA today submitted a letter to the Office of Science and Technology Policy in response to its request for information on regulatory reform for artificial…
Headline
The AHA and Federation of American Hospitals Aug. 8 filed an amicus brief in the U.S. District Court for the Eastern District of Texas in support of the U.S.…
Headline
President Trump Aug. 7 issued an executive order, “Improving Oversight of Federal Grantmaking,” requiring government agencies to review new and discretionary…